[Type-2 diabetes mellitus as a cause of disability]
- PMID: 15810510
[Type-2 diabetes mellitus as a cause of disability]
Abstract
Type 2 diabetes is a metabolic disease associated with a wide range of comorbidities and complications, including retinopathy and loss of vision, nephropathy and end-stage renal disease, peripheral neuropathy, cardiovascular diseases, lower extremity amputations due to diabetic foot. All this long-term medical complications shorten life expectancy of the affected people and cause physical decline, which leads to disability. The importance of the problem results also from the prevalence of the disease. Diabetes is expected to increase worldwide from 135 million to 300 million people between 1995 and 2025. In Poland it is estimated that 2 million inhabitants have diabetes and half of these population is unaware of the condition. The aim of these review of the literature is to show all positive associations between diabetes and its complications leading to limitations and disability. The prevalence of the disability in the population of the people with diabetes is the sum of all diabetic complications and the process of aging. The diabetes epidemic affects the entire age range and the greatest absolute increase is occurring among the elderly. These informations suggest that the number of people at risk for physical limitations and disability, caused by diabetes will increase dramatically. If these process was not stopped, it would erode health status and quality of life of the great proportion of the society.
Similar articles
-
[Prevalence of diabetes, antidiabetic treatment and chronic diabetic complications reported by general practitioners].Przegl Lek. 2005;62(4):201-5. Przegl Lek. 2005. PMID: 16229234 Polish.
-
Diabetic microvascular complications: can patients at risk be identified? A review.Int J Clin Pract. 2006 Nov;60(11):1471-83. doi: 10.1111/j.1742-1241.2006.01175.x. Int J Clin Pract. 2006. PMID: 17073842 Review.
-
The global burden of diabetes and its complications: an emerging pandemic.Eur J Cardiovasc Prev Rehabil. 2010 May;17 Suppl 1:S3-8. doi: 10.1097/01.hjr.0000368191.86614.5a. Eur J Cardiovasc Prev Rehabil. 2010. PMID: 20489418 Review.
-
Cross-sectional analysis of adult diabetes type 1 and type 2 patients with diabetic microvascular complications from a German retrospective observational study.Curr Med Res Opin. 2007 Jun;23(6):1367-74. doi: 10.1185/030079907X188215. Epub 2007 May 21. Curr Med Res Opin. 2007. PMID: 17559744
-
Increased prevalence of microvascular complications in type 2 diabetes patients with the metabolic syndrome.Isr Med Assoc J. 2006 Jun;8(6):378-82. Isr Med Assoc J. 2006. PMID: 16833164
Cited by
-
Glimepiride-Loaded Nanoemulgel; Development, In Vitro Characterization, Ex Vivo Permeation and In Vivo Antidiabetic Evaluation.Cells. 2021 Sep 13;10(9):2404. doi: 10.3390/cells10092404. Cells. 2021. PMID: 34572054 Free PMC article.
-
The glucotoxicity protecting effect of honokiol in human hepatocytes via directly activating AMPK.Front Nutr. 2022 Nov 18;9:1043009. doi: 10.3389/fnut.2022.1043009. eCollection 2022. Front Nutr. 2022. PMID: 36466390 Free PMC article.